DIA vs IBB
SPDR Dow Jones Industrial Average ETF vs iShares Biotechnology ETF
- • DIA has the lower expense ratio at 0.16% vs 0.44% for IBB.
- • DIA pays a higher dividend yield (1.42%).
Side-by-side metrics
| Metric | DIA | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.16% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.42% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $42.72B | $7.95B |
YTD return | 4.28% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.87 | 0.74 |
P/E ratio | 23.68 | 23.72 |
Last price | $495.91 | $170.10 |
Inception | — | — |
Issuer | State Street | iShares |
DIA top holdings
| GS | The Goldman Sachs Group Inc | 11.45% |
| CAT | Caterpillar Inc | 11.03% |
| MSFT | Microsoft Corp | 5.05% |
| UNH | UnitedHealth Group Inc | 4.59% |
| AMGN | Amgen Inc | 4.29% |
| V | Visa Inc Class A | 4.09% |
| HD | The Home Depot Inc | 4.07% |
| AXP | American Express Co | 4.00% |
| SHW | Sherwin-Williams Co | 3.98% |
| JPM | JPMorgan Chase & Co | 3.88% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About DIA
DIA (SPDR Dow Jones Industrial Average ETF) is Tracks the 30-stock Dow Jones Industrial Average. Managed by State Street, the fund carries $42.7B in assets under management, an expense ratio of 0.16%, a dividend yield of 1.42%. Its largest holding is The Goldman Sachs Group Inc (GS), which represents 11.4% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 11.6%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.